Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Seoyoung Catherine Kim, Sc.D., M.D.

Title
Institution
Department
Address
Phone
Profile Picture
Other Positions
Title
Institution
Department

Biography
awards and honors
2014
BWH DOM Early Career Mentoring Award
2014
Harvard Catalyst Clinical Research Center Batch Sample Analysis and Assay Validation Award
2016
Chair's Research Award
2021
Henry Kunkel Early Career Investigator Award

Overview
overview
Seoyoung C. Kim, M.D, Sc.D, M.S.C.E, is an Associate Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. She is the Director of the Program in Rheumatologic, Immunologic, and Musculoskeletal PharmacoEpidemiology (PRIME).

She is board-certified in Rheumatology, and co-appointed in the Division of Rheumatology, Immunology and Allergy at Brigham and Women’s Hospital. Her research focuses on comparative safety and effectiveness of medications for the rheumatic diseases as well as health services/outcome research in Rheumatology.
Dr. Kim is an Associate Editor for Arthritis Care & Research and ACR Open Rheumatology and has served on a number of Committees for the American College of Rheumatology and the International Society for Pharmacoepidemiology.
media links

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. K24AR078959 (KIM, SEOYOUNG CATHERINE) Apr 1, 2021 - Mar 31, 2026
    NIH
    Mentoring Patient-Oriented Pharmacoepidemiologic Research in Rheumatic Diseases
    Role: Principal Investigator
  2. R01AR073314 (KIM, SEOYOUNG CATHERINE) Jul 10, 2019 - May 31, 2022
    NIH
    Comparative Effectiveness of Treat-To-Target Approach versus Routine Care in Management of Gout
    Role: Principal Investigator
  3. R01AR069557 (KIM, SEOYOUNG CATHERINE) Sep 19, 2016 - Feb 28, 2021
    NIH
    Use and safety of opioids in patients undergoing total joint replacement
    Role: Principal Investigator
  4. R21AR069271 (KIM, SEOYOUNG CATHERINE) Mar 1, 2016 - Feb 28, 2018
    NIH
    Xanthine oxidase inhibitors and risks of myocardial infarction and diabetes
    Role: Principal Investigator
  5. K23AR059677 (KIM, SEOYOUNG CATHERINE) Aug 1, 2010 - Jul 31, 2015
    NIH
    Cervical Dysplasia and Human Papillomavirus Infection in Rheumatoid Arthritis.
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Htoo PT, Paik JM, Alt E, Kim DH, Wexler DJ, Kim SC, Patorno E. Risk of severe hypoglycemia with newer second-line glucose-lowering medications in older adults with type 2 diabetes stratified by known indicators of hypoglycemia risk. J Gerontol A Biol Sci Med Sci. 2023 Mar 02. PMID: 36866496.
    Citations:    Fields:    
  2. D'Andrea E, Wexler DJ, Kim SC, Paik JM, Alt E, Patorno E. Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels. JAMA Intern Med. 2023 03 01; 183(3):242-254. PMID: 36745425; PMCID: PMC9989905.
    Citations:    Fields:    Translation:Humans
  3. Lee H, Sparks JA, Lee SB, Yoshida K, Landon JE, Kim SC. Validation of serostatus of rheumatoid arthritis using ICD-10 codes in administrative claims data. Pharmacoepidemiol Drug Saf. 2023 Feb 02. PMID: 36728737.
    Citations:    Fields:    
  4. Ingrasciotta Y, Jin Y, Foti SS, Landon JE, Tari M, Mattace-Raso F, Kim SC, Trifirò G. Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a cross-national study. Clin Rheumatol. 2023 Apr; 42(4):1047-1059. PMID: 36534353; PMCID: PMC10017582.
    Citations:    Fields:    
  5. Chandler MT, Santacroce LM, Costenbader KH, Kim SC, Feldman CH. Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus. Semin Arthritis Rheum. 2023 02; 58:152122. PMID: 36372014; PMCID: PMC9976620.
    Citations:    Fields:    Translation:Humans
  6. Desai RJ, Mahesri M, Lee SB, Varma VR, Loeffler T, Schilcher I, Gerhard T, Segal JB, Ritchey ME, Horton DB, Kim SC, Schneeweiss S, Thambisetty M. No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study. Brain Commun. 2022; 4(5):fcac247. PMID: 36330433.
    Citations:    
  7. Zhuo M, D'Andrea E, Paik JM, Wexler DJ, Everett BM, Glynn RJ, Kim SC, Patorno E. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes. JAMA Netw Open. 2022 10 03; 5(10):e2235995. PMID: 36219443; PMCID: PMC9554705.
    Citations: 1     Fields:    Translation:Humans
  8. Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Kim SC, Najafzadeh M, Koeneman L, Farsani SF, Déruaz-Luyet A, Paik JM, Patorno E. Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics. JAMA Netw Open. 2022 10 03; 5(10):e2237606. PMID: 36264574; PMCID: PMC9585433.
    Citations:    Fields:    Translation:Humans
  9. Khosrow-Khavar F, Desai RJ, Lee H, Lee SB, Kim SC. Tofacitinib and Risk of Malignancy: Results From the Safety of Tofacitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA) Study. Arthritis Rheumatol. 2022 10; 74(10):1648-1659. PMID: 35643956; PMCID: PMC9529806.
    Citations: 3     Fields:    Translation:Humans
  10. Lauffenburger JC, Lu Z, Mahesri M, Kim E, Tong A, Kim SC. Using Data-Driven Approaches to Classify and Predict Health Care Spending in Patients With Gout Using Urate-Lowering Therapy. Arthritis Care Res (Hoboken). 2022 Aug 30. PMID: 36039962.
    Citations:    Fields:    
  11. Jin Y, Lee H, Lee MP, Landon JE, Merola JF, Desai RJ, Kim SC. Risk of Hospitalization for Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic Arthritis. Arthritis Care Res (Hoboken). 2022 11; 74(11):1792-1805. PMID: 33973371.
    Citations: 4     Fields:    Translation:Humans
  12. D'Andrea E, Desai RJ, He M, Glynn RJ, Lee H, Weinblatt ME, Kim SC. Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis. J Am Coll Cardiol. 2022 07 05; 80(1):36-46. PMID: 35772915; PMCID: PMC9722228.
    Citations: 1     Fields:    Translation:Humans
  13. Jin Y, Landon JE, Krueger W, Liede A, Desai RJ, Kim SC. Predictors of Treatment Change Among Patients with Rheumatoid Arthritis Treated with TNF Inhibitors as First-Line Biologic Agent in the USA: A Cohort Study from Longitudinal Electronic Health Records. BioDrugs. 2022 Jul; 36(4):521-535. PMID: 35771381.
    Citations:    Fields:    Translation:Humans
  14. Roh M, Tesfaye H, Kim SC, Zabotka LE, Patorno E. Cardiovascular and Mortality Risk with Intravitreal Vascular Endothelial Growth Factor Inhibitors in Patients with Diabetic Retinopathy. Ophthalmol Retina. 2022 12; 6(12):1145-1153. PMID: 35777664.
    Citations:    Fields:    Translation:Humans
  15. Barbulescu A, Askling J, Saevarsdottir S, Kim SC, Frisell T. Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational Data. Clin Pharmacol Ther. 2022 10; 112(4):836-845. PMID: 35652244; PMCID: PMC9540175.
    Citations:    Fields:    Translation:Humans
  16. Lee H, Chen SK, Gautam N, Vine SM, He M, Desai RJ, Weinblatt ME, Glynn RJ, Kim SC. Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study. Clin Exp Rheumatol. 2023 Jan; 41(1):110-117. PMID: 35616586; PMCID: PMC9652105.
    Citations: 1     Fields:    Translation:Humans
  17. Gopalakrishnan C, Desai RJ, Franklin JM, Jin Y, Lii J, Solomon DH, Katz JN, Lee YC, Franklin PD, Kim SC. Development of a Medicare Claims-Based Model to Predict Persistent High-Dose Opioid Use After Total Knee Replacement. Arthritis Care Res (Hoboken). 2022 08; 74(8):1342-1348. PMID: 33450136; PMCID: PMC8280246.
    Citations:    Fields:    Translation:Humans
  18. Zhuo M, Kim SC, Patorno E, Paik JM. Risk of Hospitalization for Heart Failure in Patients With Hyperkalemia Treated With Sodium Zirconium Cyclosilicate Versus Patiromer. J Card Fail. 2022 09; 28(9):1414-1423. PMID: 35470055.
    Citations: 2     Fields:    Translation:Humans
  19. Kirchgesner J, Desai RJ, Schneeweiss MC, Beaugerie L, Schneeweiss S, Kim SC. Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's disease. Gut. 2022 09; 71(9):1781-1789. PMID: 35387877.
    Citations:    Fields:    Translation:Humans
  20. Desai RJ, Varma VR, Gerhard T, Segal J, Mahesri M, Chin K, Horton DB, Kim SC, Schneeweiss S, Thambisetty M. Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents. JAMA Netw Open. 2022 04 01; 5(4):e226567. PMID: 35394510; PMCID: PMC8994126.
    Citations: 3     Fields:    Translation:Humans
  21. Kaze AD, Zhuo M, Kim SC, Patorno E, Paik JM. Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis. Cardiovasc Diabetol. 2022 03 23; 21(1):47. PMID: 35321742; PMCID: PMC9491404.
    Citations: 8     Fields:    Translation:Humans
  22. Hawley CE, Lauffenburger JC, Paik JM, Wexler DJ, Kim SC, Patorno E. Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries. Diabetes Care. 2022 03 01; 45(3):604-613. PMID: 35043165; PMCID: PMC8918201.
    Citations:    Fields:    Translation:Humans
  23. Li L, Landon JE, Kim SC. Trends in pharmacologic treatment of chronic idiopathic urticaria from 2016 to 2020. Ann Allergy Asthma Immunol. 2022 05; 128(5):602-603. PMID: 35227905; PMCID: PMC9058201.
    Citations:    Fields:    Translation:Humans
  24. Khosrow-Khavar F, Kim SC, Lee H, Lee SB, Desai RJ. Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study. Ann Rheum Dis. 2022 06; 81(6):798-804. PMID: 35027405; PMCID: PMC9117457.
    Citations: 10     Fields:    Translation:Humans
  25. Patorno E, Htoo PT, Glynn RJ, Schneeweiss S, Wexler DJ, Pawar A, Bessette LG, Chin K, Everett BM, Kim SC. Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease. Ann Intern Med. 2022 01; 175(1):W4-W5. PMID: 35038404.
    Citations:    Fields:    Translation:Humans
  26. Patorno E, Htoo PT, Everett BM, Kim SC. Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease. Ann Intern Med. 2022 01; 175(1):W4. PMID: 35038405.
    Citations:    Fields:    Translation:Humans
  27. Desai RJ, Pawar A, Khosrow-Khavar F, Weinblatt ME, Kim SC. Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study. Rheumatology (Oxford). 2021 12 24; 61(1):121-130. PMID: 33752237.
    Citations: 10     Fields:    Translation:Humans
  28. Paik JM, Patorno E, Zhuo M, Bessette LG, York C, Gautam N, Kim DH, Kim SC. Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data. Pharmacoepidemiol Drug Saf. 2022 04; 31(4):467-475. PMID: 34908211; PMCID: PMC8917076.
    Citations: 6     Fields:    Translation:Humans
  29. Tedeschi SK, Jin Y, Vine S, Lee H, Pethoe-Schramm A, Yau V, Kim SC. Giant cell arteritis treatment patterns and rates of serious infections. Clin Exp Rheumatol. 2022 May; 40(4):826-833. PMID: 34905480.
    Citations: 1     Fields:    Translation:Humans
  30. Paik JM, Zhuo M, York C, Tsacogianis T, Kim SC, Desai RJ. Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013-2017. Am J Nephrol. 2021; 52(12):919-928. PMID: 34814147; PMCID: PMC8979193.
    Citations:    Fields:    Translation:Humans
  31. Kang EH, Park EH, Shin A, Song JS, Kim SC. Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout. Eur Heart J. 2021 11 21; 42(44):4578-4588. PMID: 34508567.
    Citations: 9     Fields:    Translation:Humans
  32. Suissa K, Kim SC, Patorno E. Misclassification of Obesity in Claims Data. Clin Transl Gastroenterol. 2021 11 18; 12(11):e00423. PMID: 34797225; PMCID: PMC8604028.
    Citations: 1     Fields:    Translation:Humans
  33. Zhuo M, Paik JM, Wexler DJ, Bonventre JV, Kim SC, Patorno E. SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 Diabetes. Am J Kidney Dis. 2022 06; 79(6):858-867.e1. PMID: 34762974; PMCID: PMC9079190.
    Citations: 6     Fields:    Translation:Humans
  34. He M, Pawar A, Desai RJ, Glynn RJ, Lee H, Weinblatt ME, Solomon DH, Kim SC. Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study. Semin Arthritis Rheum. 2021 12; 51(6):1242-1250. PMID: 34757241.
    Citations: 3     Fields:    Translation:Humans
  35. Cho SK, Liu J, Jin Y, Kim SC. Risk of Non-Vertebral Fracture in Gout Compared to Rheumatoid Arthritis. J Clin Med. 2021 Oct 11; 10(20). PMID: 34682784.
    Citations:    
  36. Huang S, Cai T, Weber BN, He Z, Dahal KP, Hong C, Hou J, Seyok T, Cagan A, DiCarli MF, Joseph J, Kim SC, Solomon DH, Cai T, Liao KP. Association Between Inflammation, Incident Heart Failure, and Heart Failure Subtypes in Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021 Oct 08. PMID: 34623035; PMCID: PMC8989720.
    Citations:    Fields:    
  37. Zhuo M, Hawley CE, Paik JM, Bessette LG, Wexler DJ, Kim DH, Tong AY, Kim SC, Patorno E. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes. JAMA Netw Open. 2021 10 01; 4(10):e2130762. PMID: 34705014; PMCID: PMC8552056.
    Citations: 8     Fields:    Translation:Humans
  38. Park SH, Jeon HL, Kim SC, Hillen J, Gadzhanova S, Shin JY, Pratt N. Utilization of targeted disease-modifying anti-rheumatic drugs (DMARDs) for managing rheumatoid arthritis in the last decade: A two-country comparison. Int J Clin Pharmacol Ther. 2021 Oct; 59(10):639-644. PMID: 34236304.
    Citations: 1     Fields:    Translation:Humans
  39. Patorno E, Htoo PT, Glynn RJ, Schneeweiss S, Wexler DJ, Pawar A, Bessette LG, Chin K, Everett BM, Kim SC. Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease. Ann Intern Med. 2021 11; 174(11):1528-1541. PMID: 34570599; PMCID: PMC8969214.
    Citations: 18     Fields:    Translation:Humans
  40. Kirchgesner J, Desai RJ, Schneeweiss MC, Beaugerie L, Kim SC, Schneeweiss S. Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy. Pharmacoepidemiol Drug Saf. 2022 02; 31(2):167-175. PMID: 34498314.
    Citations: 1     Fields:    Translation:Humans
  41. Bröms G, Friedman S, Kim SC, Wood ME, Hernandez-Diaz S, Brill G, Bateman BT, Huybrechts KF, Desai RJ. The Patterns of Use of Medications for Inflammatory Bowel Disease During Pregnancy in the US and Sweden Are Changing. Inflamm Bowel Dis. 2021 08 19; 27(9):1427-1434. PMID: 33751058.
    Citations:    Fields:    Translation:Humans
  42. Suissa K, Schneeweiss S, Lin KJ, Brill G, Kim SC, Patorno E. Validation of obesity-related diagnosis codes in claims data. Diabetes Obes Metab. 2021 12; 23(12):2623-2631. PMID: 34338404; PMCID: PMC8578343.
    Citations: 4     Fields:    Translation:Humans
  43. Harris ST, Patorno E, Zhuo M, Kim SC, Paik JM. Prescribing Trends of Antidiabetes Medications in Patients With Type 2 Diabetes and Diabetic Kidney Disease, a Cohort Study. Diabetes Care. 2021 Aug 03. PMID: 34344714; PMCID: PMC8929186.
    Citations: 5     Fields:    
  44. Sparks JA, Jin Y, Cho SK, Vine S, Desai R, Doyle TJ, Kim SC. Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients. Rheumatology (Oxford). 2021 08 02; 60(8):3689-3698. PMID: 33462611; PMCID: PMC8328504.
    Citations: 9     Fields:    Translation:Humans
  45. Choi MY, Li D, Feldman CH, Yoshida K, Guan H, Kim SC, Everett BM, Costenbader KH. Comparative risks of cardiovascular disease events among SLE patients receiving immunosuppressive medications. Rheumatology (Oxford). 2021 08 02; 60(8):3789-3798. PMID: 33369672.
    Citations: 2     Fields:    Translation:Humans
  46. Jin Y, Chen SK, Lee H, Landon JE, Merola JF, Kim SC. Patient characteristics associated with use of TNF vs interleukin inhibitors as first-line biologic treatment for psoriatic arthritis. J Manag Care Spec Pharm. 2021 Aug; 27(8):1106-1117. PMID: 34337987.
    Citations:    Fields:    Translation:Humans
  47. Jeon HL, Kim SC, Park SH, Shin JY. The risk of serious infection in rheumatoid arthritis patients receiving tocilizumab compared with tumor necrosis factor inhibitors in Korea. Semin Arthritis Rheum. 2021 10; 51(5):989-995. PMID: 34403814.
    Citations: 2     Fields:    Translation:Humans
  48. Pawar A, Desai RJ, He M, Bessette L, Kim SC. Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs. ACR Open Rheumatol. 2021 Aug; 3(8):531-539. PMID: 34196497.
    Citations: 1     
  49. Schneeweiss MC, Kim SC, Wyss R, Jin Y, Chin K, Merola JF, Mostaghimi A, Silverberg JI, Schneeweiss S. Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases. JAMA Dermatol. 2021 Jul 01; 157(7):805-816. PMID: 34037662; PMCID: PMC8156173.
    Citations: 5     Fields:    Translation:Humans
  50. Shin A, Lee YJ, Lee EB, Song YW, Kim SC, Kang EH. Tuberculosis risk with biologics by screening-guided preventive strategy in rheumatoid arthritis under intermediate tuberculosis burden. Rheumatology (Oxford). 2021 06 18; 60(6):2755-2764. PMID: 33188421.
    Citations:    Fields:    Translation:Humans
  51. Kirchgesner J, Desai RJ, Beaugerie L, Kim SC, Schneeweiss S. Calibrating Real-World Evidence Studies Against Randomized Trials: Treatment Effectiveness of Infliximab in Crohn's Disease. Clin Pharmacol Ther. 2022 01; 111(1):179-186. PMID: 34027993.
    Citations: 1     Fields:    Translation:Humans
  52. Cromer SJ, D'Silva KM, Yu EW, Landon J, Desai RJ, Kim SC. Secular Trends in the Pharmacologic Treatment of Osteoporosis and Malignancy-Related Bone Disease from 2009 to 2020. J Gen Intern Med. 2022 06; 37(8):1917-1924. PMID: 34100235; PMCID: PMC9198174.
    Citations:    Fields:    Translation:Humans
  53. Johansson FD, Collins JE, Yau V, Guan H, Kim SC, Losina E, Sontag D, Stratton J, Trinh H, Greenberg J, Solomon DH. Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-world Data Analysis Using Machine Learning. J Rheumatol. 2021 09; 48(9):1364-1370. PMID: 33934070.
    Citations: 4     Fields:    Translation:Humans
  54. Liew JW, Kim SC, Peloquin C, Felson DT, Jin Y, Lii J, Neogi T. Knee osteonecrosis incidence from two real-world data sources. Osteoarthr Cartil Open. 2021 Jun; 3(2). PMID: 33959724; PMCID: PMC8096165.
    Citations:    
  55. Pawar A, Desai RJ, Liu J, Kim E, Kim SC. Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol. J Am Heart Assoc. 2021 04 06; 10(7):e020045. PMID: 33764153.
    Citations: 3     Fields:    Translation:Humans
  56. Lee H, He M, Cho SK, Bessette L, Tong AY, Merola JF, Wegrzyn LR, Kilpatrick RD, Kim SC. Validation of claims-based algorithms to identify patients with psoriasis. Pharmacoepidemiol Drug Saf. 2021 07; 30(7):868-874. PMID: 33715280.
    Citations: 1     Fields:    Translation:Humans
  57. Kim SC, Neogi T, Kim E, Lii J, Desai RJ. Trends in Utilization of Urate-Lowering Therapies Following the US Food and Drug Administration's Boxed Warning on Febuxostat. Arthritis Rheumatol. 2021 03; 73(3):542-543. PMID: 33029931; PMCID: PMC7914144.
    Citations: 2     Fields:    Translation:Humans
  58. Patorno E, Pawar A, Bessette LG, Kim DH, Dave C, Glynn RJ, Munshi MN, Schneeweiss S, Wexler DJ, Kim SC. Comparative Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults. Diabetes Care. 2021 03; 44(3):826-835. PMID: 33495295; PMCID: PMC7896266.
    Citations: 17     Fields:    Translation:Humans
  59. Lee H, Tedeschi SK, Chen SK, Monach PA, Kim E, Liu J, Pethoe-Schramm A, Yau V, Kim SC. Identification of Acute Giant Cell Arteritis in Real-World Data Using Administrative Claims-Based Algorithms. ACR Open Rheumatol. 2021 Feb; 3(2):72-78. PMID: 33491920.
    Citations:    
  60. Solomon DH, Xu C, Collins J, Kim SC, Losina E, Yau V, Johansson FD. The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy. Arthritis Res Ther. 2021 01 14; 23(1):26. PMID: 33446261.
    Citations: 3     Fields:    Translation:Humans
  61. Kirchgesner J, Desai RJ, Beaugerie L, Schneeweiss S, Kim SC. Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022 02; 20(2):314-324.e16. PMID: 33387667.
    Citations: 11     Fields:    Translation:Humans
  62. Dave CV, Kim SC, Goldfine AB, Glynn RJ, Tong A, Patorno E. Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy. Circulation. 2021 02 23; 143(8):770-779. PMID: 33302723; PMCID: PMC7902404.
    Citations: 16     Fields:    Translation:Humans
  63. Chen SK, Liu J, Kim SC. Real-world patterns of pegloticase use for treatment of gout: descriptive multidatabase cohort study. BMJ Open. 2020 12 07; 10(12):e041167. PMID: 33293318.
    Citations: 1     Fields:    Translation:Humans
  64. Desai RJ, Varma VR, Gerhard T, Segal J, Mahesri M, Chin K, Nonnenmacher E, Gabbeta A, Mammen AM, Varma S, Horton DB, Kim SC, Schneeweiss S, Thambisetty M. Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study. Alzheimers Dement (N Y). 2020; 6(1):e12095. PMID: 33304987.
    Citations: 7     
  65. D'Silva KM, Cromer SJ, Yu EW, Fischer M, Kim SC. Risk of Incident Atrial Fibrillation With Zoledronic Acid Versus Denosumab: A Propensity Score-Matched Cohort Study. J Bone Miner Res. 2021 01; 36(1):52-60. PMID: 33137852.
    Citations: 4     Fields:    Translation:Humans
  66. Schneeweiss MC, Kim SC, Wyss R, Schneeweiss S, Merola JF. Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: A propensity score-matched cohort study. J Am Acad Dermatol. 2021 Feb; 84(2):300-311. PMID: 33038471.
    Citations: 6     Fields:    Translation:Humans
  67. Kang EH, Jin Y, Tong AY, Desai RJ, Kim SC. Risk of Serious Infection Among Initiators of Tumor Necrosis Factor Inhibitors Plus Methotrexate Versus Triple Therapy for Rheumatoid Arthritis: A Cohort Study. Arthritis Care Res (Hoboken). 2020 10; 72(10):1383-1391. PMID: 31376333.
    Citations: 4     Fields:    Translation:Humans
  68. Huybrechts KF, Bateman BT, Zhu Y, Straub L, Mogun H, Kim SC, Desai RJ, Hernandez-Diaz S. Hydroxychloroquine early in pregnancy and risk of birth defects. Am J Obstet Gynecol. 2021 03; 224(3):290.e1-290.e22. PMID: 32961123; PMCID: PMC7501839.
    Citations: 18     Fields:    Translation:HumansCells
  69. Jin Y, Chen SK, Liu J, Kim SC. Risk of Incident Type 2 Diabetes Mellitus Among Patients With Rheumatoid Arthritis: A Population-Based Cohort Study. Arthritis Care Res (Hoboken). 2020 09; 72(9):1248-1256. PMID: 32754989.
    Citations: 4     Fields:    Translation:Humans
  70. Fralick M, Kim SC, Schneeweiss S, Everett BM, Glynn RJ, Patorno E. Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study. BMJ. 2020 08 25; 370:m2812. PMID: 32843476; PMCID: PMC7445737.
    Citations: 10     Fields:    Translation:Humans
  71. Chen SK, Lee H, Jin Y, Liu J, Kim SC. Use of biologic or targeted-synthetic disease-modifying anti-rheumatic drugs and risk of diabetes treatment intensification in patients with rheumatoid arthritis and diabetes mellitus. Rheumatol Adv Pract. 2020; 4(2):rkaa027. PMID: 32914050; PMCID: PMC7474857.
    Citations: 8     
  72. Barberio J, Kim SC, Roh M, Lewis JD, Desai RJ. Risk of Uveitis in Patients With Inflammatory Bowel Disease on Immunosuppressive Drug Therapy. Crohns Colitis 360. 2020 Jul; 2(3):otaa041. PMID: 36776495; PMCID: PMC9802084.
    Citations:    
  73. Jensen TB, Kim SC, Jimenez-Solem E, Bartels D, Christensen HR, Andersen JT. Shift From Adalimumab Originator to Biosimilars in Denmark. JAMA Intern Med. 2020 06 01; 180(6):902-903. PMID: 32227137; PMCID: PMC7105946.
    Citations: 21     Fields:    Translation:Humans
  74. Cho SK, Doyle TJ, Lee H, Jin Y, Tong AY, Ortiz AJS, Sparks JA, Kim SC. Validation of claims-based algorithms to identify interstitial lung disease in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2020 08; 50(4):592-597. PMID: 32480097.
    Citations: 7     Fields:    Translation:Humans
  75. Kim SC, Bateman BT. Methodological Challenges in Conducting Large-Scale Real-World Data Analyses on Opioid Use in Musculoskeletal Disorders. J Bone Joint Surg Am. 2020 May 20; 102 Suppl 1:10-14. PMID: 32251129.
    Citations: 3     Fields:    Translation:Humans
  76. Bedard NA, Schoenfeld AJ, Kim SC. Optimum Designs for Large Database Research in Musculoskeletal Pain Management. J Bone Joint Surg Am. 2020 May 20; 102 Suppl 1:54-58. PMID: 32251134.
    Citations: 2     Fields:    Translation:Humans
  77. FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, Gelber AC, Harrold LR, Khanna D, King C, Levy G, Libbey C, Mount D, Pillinger MH, Rosenthal A, Singh JA, Sims JE, Smith BJ, Wenger NS, Bae SS, Danve A, Khanna PP, Kim SC, Lenert A, Poon S, Qasim A, Sehra ST, Sharma TSK, Toprover M, Turgunbaev M, Zeng L, Zhang MA, Turner AS, Neogi T. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Rheumatol. 2020 06; 72(6):879-895. PMID: 32390306.
    Citations: 73     Fields:    Translation:Humans
  78. FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, Gelber AC, Harrold LR, Khanna D, King C, Levy G, Libbey C, Mount D, Pillinger MH, Rosenthal A, Singh JA, Sims JE, Smith BJ, Wenger NS, Bae SS, Danve A, Khanna PP, Kim SC, Lenert A, Poon S, Qasim A, Sehra ST, Sharma TSK, Toprover M, Turgunbaev M, Zeng L, Zhang MA, Turner AS, Neogi T. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020 06; 72(6):744-760. PMID: 32391934.
    Citations: 103     Fields:    Translation:Humans
  79. Desai RJ, Dejene S, Jin Y, Liu J, Kim SC. Comparative Risk of Diabetes Mellitus in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Drugs: A Cohort Study. ACR Open Rheumatol. 2020 Apr; 2(4):222-231. PMID: 32267094; PMCID: PMC7164631.
    Citations: 5     
  80. Kim SC, Sarpatwari A, Landon JE, Desai RJ. Utilization and Treatment Costs of Tumor Necrosis Factor Inhibitors After the Introduction of Biosimilar Infliximab in the United States. Arthritis Rheumatol. 2020 06; 72(6):1036-1038. PMID: 31943866.
    Citations: 4     Fields:    Translation:Humans
  81. Lee H, Jin Y, Roh M, Tsacogianis TN, Park S, Choi NK, Kim SC. Risk of Cataract Surgery and Age-Related Macular Degeneration After Initiation of Denosumab vs Zoledronic Acid for Osteoporosis: A Multi-Database Cohort Study. Drugs Aging. 2020 04; 37(4):311-320. PMID: 32026309.
    Citations: 1     Fields:    Translation:Humans
  82. Schneeweiss MC, Kim SC, Schneeweiss S, Rosmarin D, Merola JF. Risk of Inflammatory Arthritis After a New Diagnosis of Hidradenitis Suppurativa. JAMA Dermatol. 2020 03 01; 156(3):342-345. PMID: 31968066; PMCID: PMC6990727.
    Citations: 5     Fields:    Translation:Humans
  83. Kim SC, Solomon DH. Towards defining the safer use of opioids in rheumatology. Nat Rev Rheumatol. 2020 Feb; 16(2):71-72. PMID: 31889161.
    Citations: 3     Fields:    Translation:Humans
  84. Fralick M, Chen SK, Patorno E, Kim SC. Assessing the Risk for Gout With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Population-Based Cohort Study. Ann Intern Med. 2020 02 04; 172(3):186-194. PMID: 31931526; PMCID: PMC7217750.
    Citations: 20     Fields:    Translation:Humans
  85. Collins JE, Johansson FD, Gale S, Kim S, Shrestha S, Sontag D, Stratton J, Trinh H, Xu C, Losina E, Solomon DH. Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development. ACR Open Rheumatol. 2020 Feb; 2(2):65-73. PMID: 32043832; PMCID: PMC7011418.
    Citations: 3     
  86. Kim SC, Schneeweiss S. When Randomized Clinical Trials and Real-World Evidence Say the Same: Tocilizumab and Its Cardiovascular Safety. Arthritis Rheumatol. 2020 01; 72(1):4-6. PMID: 31469243.
    Citations: 3     Fields:    Translation:Humans
  87. He M, Santiago Ortiz AJ, Marshall J, Mendelsohn AB, Curtis JR, Barr CE, Lockhart CM, Kim SC. Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare Data. Pharmacoepidemiol Drug Saf. 2020 07; 29(7):770-777. PMID: 31854053.
    Citations: 5     Fields:    Translation:Humans
  88. Lee H, Ford JA, Jin Y, Cho SK, Santiago Ortiz AJ, Tong AY, Kim SC. Validation of claims-based algorithms for psoriatic arthritis. Pharmacoepidemiol Drug Saf. 2020 04; 29(4):404-408. PMID: 31849154.
    Citations: 2     Fields:    Translation:Humans
  89. Lee H, Jin Y, Liu J, Cohen EM, Chen SK, Kim SC. Risk of Diabetes Mellitus in Patients with Juvenile Idiopathic Arthritis. J Rheumatol. 2020 09 01; 47(9):1405-1408. PMID: 31787600.
    Citations: 1     Fields:    Translation:Humans
  90. Kang EH, Choi HK, Shin A, Lee YJ, Lee EB, Song YW, Kim SC. Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study. Rheumatology (Oxford). 2019 12 01; 58(12):2122-2129. PMID: 31098635.
    Citations: 8     Fields:    Translation:Humans
  91. Chen SK, Liao KP, Liu J, Kim SC. Risk of Hospitalized Infection and Initiation of Abatacept Versus Tumor Necrosis Factor Inhibitors Among Patients With Rheumatoid Arthritis: A Propensity Score-Matched Cohort Study. Arthritis Care Res (Hoboken). 2020 01; 72(1):9-17. PMID: 30570833.
    Citations: 10     Fields:    Translation:Humans
  92. Kang EH, Jin Y, Desai RJ, Liu J, Sparks JA, Kim SC. Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort study. Semin Arthritis Rheum. 2020 06; 50(3):401-408. PMID: 31813561.
    Citations: 5     Fields:    Translation:Humans
  93. Dommasch ED, Kim SC, Lee MP, Gagne JJ. Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis. JAMA Dermatol. 2019 Oct 01; 155(10):1142-1152. PMID: 31075163; PMCID: PMC6512303.
    Citations: 15     Fields:    
  94. Bursill D, Taylor WJ, Terkeltaub R, Abhishek A, So AK, Vargas-Santos AB, Gaffo AL, Rosenthal A, Tausche AK, Reginato A, Manger B, Sciré C, Pineda C, van Durme C, Lin CT, Yin C, Albert DA, Biernat-Kaluza E, Roddy E, Pascual E, Becce F, Perez-Ruiz F, Sivera F, Lioté F, Schett G, Nuki G, Filippou G, McCarthy G, da Rocha Castelar Pinheiro G, Ea HK, Tupinambá HA, Yamanaka H, Choi HK, Mackay J, ODell JR, Vázquez Mellado J, Singh JA, Fitzgerald JD, Jacobsson LTH, Joosten L, Harrold LR, Stamp L, Andrés M, Gutierrez M, Kuwabara M, Dehlin M, Janssen M, Doherty M, Hershfield MS, Pillinger M, Edwards NL, Schlesinger N, Kumar N, Slot O, Ottaviani S, Richette P, MacMullan PA, Chapman PT, Lipsky PE, Robinson P, Khanna PP, Gancheva RN, Grainger R, Johnson RJ, Te Kampe R, Keenan RT, Tedeschi SK, Kim S, Choi SJ, Fields TR, Bardin T, Uhlig T, Jansen T, Merriman T, Pascart T, Neogi T, Klück V, Louthrenoo W, Dalbeth N. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout. Ann Rheum Dis. 2019 11; 78(11):1592-1600. PMID: 31501138.
    Citations: 21     Fields:    Translation:Humans
  95. MacFarlane LA, Jin Y, Franklin PD, Lii J, Katz JN, Kim SC. Assessment for Perioperative Hyperglycemia Prior to Total Joint Replacement in Patients With and Without Diabetes. JAMA Netw Open. 2019 09 04; 2(9):e1910589. PMID: 31483467; PMCID: PMC6727678.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  96. Yu EW, Kim SC, Sturgeon DJ, Lindeman KG, Weissman JS. Fracture Risk After Roux-en-Y Gastric Bypass vs Adjustable Gastric Banding Among Medicare Beneficiaries. JAMA Surg. 2019 08 01; 154(8):746-753. PMID: 31090893; PMCID: PMC6537834.
    Citations: 14     Fields:    Translation:Humans
  97. Kang EH, Kim SC. Cardiovascular Safety of Urate Lowering Therapies. Curr Rheumatol Rep. 2019 07 24; 21(9):48. PMID: 31342190.
    Citations: 4     Fields:    Translation:Humans
  98. Desai RJ, Kim SC, Curtis JR, Bosco JLF, Eichelberger B, Barr CE, Lockhart CM, Bradbury BD, Clewell J, Cohen HP, Gagne JJ. Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars. Pharmacoepidemiol Drug Saf. 2020 07; 29(7):757-769. PMID: 31298463.
    Citations: 4     Fields:    Translation:Humans
  99. Yu Z, Kim SC, Vanni K, Huang J, Desai R, Murphy SN, Solomon DH, Liao KP. Correction to: Association between inflammation and systolic blood pressure in RA compared to patients without RA. Arthritis Res Ther. 2019 Jul 08; 21(1):170. PMID: 31287018; PMCID: PMC6615297.
    Citations:    Fields:    
  100. Kim SC, Jin Y, Lee YC, Lii J, Franklin PD, Solomon DH, Franklin JM, Katz JN, Desai RJ. Association of Preoperative Opioid Use With Mortality and Short-term Safety Outcomes After Total Knee Replacement. JAMA Netw Open. 2019 07 03; 2(7):e198061. PMID: 31365106.
    Citations: 19     Fields:    Translation:Humans
  101. Fralick M, Kim SC, Schneeweiss S, Kim D, Redelmeier DA, Patorno E. Fracture Risk After Initiation of Use of Canagliflozin. Ann Intern Med. 2019 07 02; 171(1):80. PMID: 31261403.
    Citations: 2     Fields:    Translation:Humans
  102. Jin Y, Solomon DH, Franklin PD, Lee YC, Lii J, Katz JN, Kim SC. Patterns of prescription opioid use before total hip and knee replacement among US Medicare enrollees. Osteoarthritis Cartilage. 2019 10; 27(10):1445-1453. PMID: 31251985; PMCID: PMC6751003.
    Citations: 5     Fields:    Translation:Humans
  103. Chen SK, Feldman CH, Brill G, Lee YC, Desai RJ, Kim SC. Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study. BMJ Open. 2019 06 19; 9(6):e027495. PMID: 31221884.
    Citations: 7     Fields:    Translation:Humans
  104. Tedeschi SK, Kim SC, Guan H, Grossman JM, Costenbader KH. Comparative Fracture Risks Among United States Medicaid Enrollees With and Those Without Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019 07; 71(7):1141-1146. PMID: 30714690; PMCID: PMC6594862.
    Citations: 10     Fields:    Translation:Humans
  105. Spoendlin J, Paik JM, Tsacogianis T, Kim SC, Schneeweiss S, Desai RJ. Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis. JAMA Intern Med. 2019 06 01; 179(6):741-749. PMID: 31058913; PMCID: PMC6503544.
    Citations: 7     Fields:    Translation:Humans
  106. Lee MP, Desai RJ, Jin Y, Brill G, Ogdie A, Kim SC. Association of Ustekinumab vs TNF Inhibitor Therapy With Risk of Atrial Fibrillation and Cardiovascular Events in Patients With Psoriasis or Psoriatic Arthritis. JAMA Dermatol. 2019 06 01; 155(6):700-707. PMID: 30916734; PMCID: PMC6563547.
    Citations: 18     Fields:    Translation:Humans
  107. Yoshida K, Solomon DH, Haneuse S, Kim SC, Patorno E, Tedeschi SK, Lyu H, Hernández-Díaz S, Glynn RJ. A tool for empirical equipoise assessment in multigroup comparative effectiveness research. Pharmacoepidemiol Drug Saf. 2019 07; 28(7):934-941. PMID: 31131965; PMCID: PMC7057252.
    Citations: 2     Fields:    Translation:Humans
  108. Desai RJ, Pawar A, Weinblatt ME, Kim SC. Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study. Arthritis Rheumatol. 2019 06; 71(6):892-900. PMID: 30552833.
    Citations: 32     Fields:    Translation:Humans
  109. Desai RJ, Jin Y, Franklin PD, Lee YC, Bateman BT, Lii J, Solomon DH, Katz JN, Kim SC. Association of Geography and Access to Health Care Providers With Long-Term Prescription Opioid Use in Medicare Patients With Severe Osteoarthritis: A Cohort Study. Arthritis Rheumatol. 2019 05; 71(5):712-721. PMID: 30688044; PMCID: PMC6483834.
    Citations: 11     Fields:    Translation:Humans
  110. Kim SC, Pawar A, Desai RJ, Solomon DH, Gale S, Bao M, Sarsour K, Schneeweiss S. Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort study. Semin Arthritis Rheum. 2019 10; 49(2):222-228. PMID: 30967248.
    Citations: 15     Fields:    Translation:Humans
  111. Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R, Pineda C, Louthrenoo W, Edwards NL, Andrés M, Vargas-Santos AB, Roddy E, Pascart T, Lin CT, Perez-Ruiz F, Tedeschi SK, Kim SC, Harrold LR, McCarthy G, Kumar N, Chapman PT, Tausche AK, Vazquez-Mellado J, Gutierrez M, da Rocha Castelar-Pinheiro G, Richette P, Pascual E, Fisher MC, Burgos-Vargas R, Robinson PC, Singh JA, Jansen TL, Saag KG, Slot O, Uhlig T, Solomon DH, Keenan RT, Scire CA, Biernat-Kaluza E, Dehlin M, Nuki G, Schlesinger N, Janssen M, Stamp LK, Sivera F, Reginato AM, Jacobsson L, Lioté F, Ea HK, Rosenthal A, Bardin T, Choi HK, Hershfield MS, Czegley C, Choi SJ, Dalbeth N. Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout. Arthritis Care Res (Hoboken). 2019 03; 71(3):427-434. PMID: 29799677; PMCID: PMC6252290.
    Citations: 23     Fields:    Translation:Humans
  112. Yoshida K, Solomon DH, Haneuse S, Kim SC, Patorno E, Tedeschi SK, Lyu H, Franklin JM, Stürmer T, Hernández-Díaz S, Glynn RJ. Multinomial Extension of Propensity Score Trimming Methods: A Simulation Study. Am J Epidemiol. 2019 03 01; 188(3):609-616. PMID: 30517602.
    Citations: 8     Fields:    Translation:Humans
  113. Pawar A, Desai RJ, Solomon DH, Santiago Ortiz AJ, Gale S, Bao M, Sarsour K, Schneeweiss S, Kim SC. Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study. Ann Rheum Dis. 2019 04; 78(4):456-464. PMID: 30679153.
    Citations: 64     Fields:    Translation:Humans
  114. Fralick M, Kim SC, Schneeweiss S, Kim D, Redelmeier DA, Patorno E. Fracture Risk After Initiation of Use of Canagliflozin: A Cohort Study. Ann Intern Med. 2019 02 05; 170(3):155-163. PMID: 30597484; PMCID: PMC6602870.
    Citations: 33     Fields:    Translation:Humans
  115. Zhang M, Solomon DH, Desai RJ, Kang EH, Liu J, Neogi T, Kim SC. Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study. Circulation. 2018 09 11; 138(11):1116-1126. PMID: 29899013; PMCID: PMC6202230.
    Citations: 34     Fields:    Translation:Humans
  116. Rishi J. Desai, Mufaddal Mahesri, Younathan Abdia, Julie Barberio, Angela Tong, Dongmu Zhang, Panagiotis Mavros, Seoyoung C. Kim, Jessica M. Franklin. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis. JAMA Network Open. 2018; 3(1):e180826. View Publication.
  117. Desai RJ, Mahesri M, Abdia Y, Barberio J, Tong A, Zhang D, Mavros P, Kim SC, Franklin JM. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis. JAMA Netw Open. 2018 07 06; 1(3):e180826. PMID: 30646034; PMCID: PMC6324295.
    Citations: 28     Fields:    Translation:Humans
  118. Kim SC, Feldman S, Moscicki AB. Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention. Rheumatology (Oxford). 2018 07 01; 57(suppl_5):v26-v33. PMID: 30137592; PMCID: PMC6099129.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  119. Kim SC, Di Carli MF, Garg RK, Vanni K, Wang P, Wohlfahrt A, Yu Z, Lu F, Campos A, Bibbo CF, Smith S, Solomon DH. Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome. BMC Rheumatol. 2018; 2:17. PMID: 30886968; PMCID: PMC6390615.
    Citations: 2     
  120. Spoendlin J, Schneeweiss S, Tsacogianis T, Paik JM, Fischer MA, Kim SC, Desai RJ. Association of Medicare's Bundled Payment Reform With Changes in Use of Vitamin D Among Patients Receiving Maintenance Hemodialysis: An Interrupted Time-Series Analysis. Am J Kidney Dis. 2018 08; 72(2):178-187. PMID: 29891194.
    Citations: 10     Fields:    Translation:Humans
  121. Yu Z, Kim SC, Vanni K, Huang J, Desai R, Murphy SN, Solomon DH, Liao KP. Association between inflammation and systolic blood pressure in RA compared to patients without RA. Arthritis Res Ther. 2018 06 01; 20(1):107. PMID: 29855349; PMCID: PMC5984318.
    Citations: 10     Fields:    Translation:Humans
  122. Kang EH, Liao KP, Kim SC. Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis. Curr Rheumatol Rep. 2018 05 30; 20(7):42. PMID: 29846814.
    Citations: 8     Fields:    Translation:Humans
  123. Jin Y, Kang EH, Brill G, Desai RJ, Kim SC. Cardiovascular (CV) Risk after Initiation of Abatacept versus TNF Inhibitors in Rheumatoid Arthritis Patients with and without Baseline CV Disease. J Rheumatol. 2018 08; 45(9):1240-1248. PMID: 29764964.
    Citations: 20     Fields:    Translation:Humans
  124. Keller SF, Lu N, Blumenthal KG, Rai SK, Yokose C, Choi JWJ, Kim SC, Zhang Y, Choi HK. Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study. Ann Rheum Dis. 2018 08; 77(8):1187-1193. PMID: 29653927; PMCID: PMC6045437.
    Citations: 15     Fields:    Translation:Humans
  125. Lee MP, Lii J, Jin Y, Desai RJ, Solomon DH, Merola JF, Kim SC. Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015. Arthritis Care Res (Hoboken). 2018 05; 70(5):791-796. PMID: 28804988.
    Citations: 3     Fields:    Translation:Humans
  126. Kim SC, Solomon DH, Rogers JR, Gale S, Klearman M, Sarsour K, Schneeweiss S. No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort study. Semin Arthritis Rheum. 2018 12; 48(3):399-405. PMID: 29673963.
    Citations: 16     Fields:    Translation:Humans
  127. Wang P, Smith SE, Garg R, Lu F, Wohlfahrt A, Campos A, Vanni K, Yu Z, Solomon DH, Kim SC. Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT. RMD Open. 2018; 4(1):e000593. PMID: 29556417; PMCID: PMC5856918.
    Citations: 11     
  128. Kim SC, Neogi T, Kang EH, Liu J, Desai RJ, Zhang M, Solomon DH. Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout. J Am Coll Cardiol. 2018 03 06; 71(9):994-1004. PMID: 29496000; PMCID: PMC5911395.
    Citations: 18     Fields:    Translation:Humans
  129. Desai RJ, Franklin JM, Spoendlin-Allen J, Solomon DH, Danaei G, Kim SC. An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout. PLoS One. 2018; 13(2):e0193622. PMID: 29489919.
    Citations: 14     Fields:    Translation:Humans
  130. Kim SC, Shah NR, Rogers JR, Bibbo CF, Di Carli MF, Solomon DH. Assessment of coronary vascular function with cardiac PET in relation to serum uric acid. PLoS One. 2018; 13(2):e0192788. PMID: 29438436.
    Citations: 3     Fields:    Translation:Humans
  131. Patorno E, Goldfine AB, Schneeweiss S, Everett BM, Glynn RJ, Liu J, Kim SC. Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study. BMJ. 2018 02 06; 360:k119. PMID: 29437648; PMCID: PMC5799855.
    Citations: 68     Fields:    Translation:Humans
  132. Kang EH, Jin Y, Brill G, Lewey J, Patorno E, Desai RJ, Kim SC. Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study. J Am Heart Assoc. 2018 01 24; 7(3). PMID: 29367417; PMCID: PMC5850244.
    Citations: 28     Fields:    Translation:Humans
  133. Bermas BL, Kim SC, Huybrechts K, Mogun H, Hernandez-Diaz S, Bateman BT, Desai RJ. Trends in use of hydroxychloroquine during pregnancy in systemic lupus erythematosus patients from 2001 to 2015. Lupus. 2018 May; 27(6):1012-1017. PMID: 29301469.
    Citations: 9     Fields:    
  134. Lin TC, Hashemi N, Kim SC, Yang YK, Yoshida K, Tedeschi S, Desai R, Solomon DH. Practice Pattern of Hepatitis B Testing in Rheumatoid Arthritis Patients: A Cross-National Comparison Between the US and Taiwan. Arthritis Care Res (Hoboken). 2018 01; 70(1):30-38. PMID: 28320050.
    Citations: 4     Fields:    Translation:HumansCells
  135. Desai RJ, Gagne JJ, Lii J, Liu J, Friedman S, Kim SC. Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-a inhibitors or nonbiologic agents: a cohort study. CMAJ. 2017 Nov 27; 189(47):E1438-E1447. PMID: 29180383; PMCID: PMC5703676.
    Citations: 7     Fields:    Translation:Humans
  136. Desai RJ, Franklin JM, Kim SC. Alendronate and Hip Fracture in Patients Using Glucocorticoids. JAMA. 2017 11 07; 318(17):1711-1712. PMID: 29114826.
    Citations:    Fields:    Translation:Humans
  137. Desai RJ, Solomon DH, Jin Y, Liu J, Kim SC. Temporal Trends in Use of Biologic DMARDs for Rheumatoid Arthritis in the United States: A Cohort Study of Publicly and Privately Insured Patients. J Manag Care Spec Pharm. 2017 Aug; 23(8):809-814. PMID: 28737992.
    Citations: 16     Fields:    Translation:Humans
  138. Jin Y, Desai RJ, Liu J, Choi NK, Kim SC. Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis. Arthritis Res Ther. 2017 07 05; 19(1):159. PMID: 28679392; PMCID: PMC5499035.
    Citations: 15     Fields:    Translation:Humans
  139. Kim SC, Solomon DH, Rogers JR, Gale S, Klearman M, Sarsour K, Schneeweiss S. Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study. Arthritis Rheumatol. 2017 06; 69(6):1154-1164. PMID: 28245350; PMCID: PMC5573926.
    Citations: 73     Fields:    Translation:Humans